Skip to content

Physiopathology, Diagnosis and Therapy of Primary Cephalalgia and Adaptive Disorders

Biomarker Identification to Predict the Evolution of Migraine From an Episodic to a Chronic Condition

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04696510
Enrollment
15
Registered
2021-01-06
Start date
2018-08-31
Completion date
2020-12-15
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

Episodic migraine, Chronic migraine, Medication overuse, Nitroglycerin, fMRI

Brief summary

The main aim of the present pilot study is to prove the possibility to use the Nitroglycerin (NTG) model to describe the pathophysiology of headache using task-free advanced Magnetic Resonance Imaging (MRI) techniques, in order to depict the static changes of the ictal and inter-ictal phase of migraine attacks vs the pain free state in healthy subjects and to compare that with the spontaneous headache attack experienced by chronic migraineurs.

Detailed description

Resting state functional magnetic resonance imaging (rs-fMRI) has depicted cyclical functional connectivity changes during the ictal and inter-ictal phase of the migraine attack. In this pilot study, Functional Connectivity (FC) changes during nitroglycerin (NTG) induced migraine attacks were assessed vs the pain-free condition in healthy subjects. To this end, subjects with episodic migraine (EM) without aura were enrolled. NTG-triggered a spontaneous-like migraine attack in the subjects. They underwent 4 rs-fMRI scan repetitions during different phases of the attack (baseline, prodromal, full blown, recovery phase) with a 3 Tesla MR scanner. According to the pain field literature, several regions of interests were studied, in particular the thalamic areas and the salience network (SN) were selected as primary areas of interest for the analyses. Subjects' rs-fMRI data were first processed with a seed-based correlation analysis (SCA) to assess the static changes in FC between the thalamus and the rest of the brain during the experiment. The wavelet coherence approach (WCA) were also applied to test the changes in time-in-phase coherence between the thalamus and the salience network (SN). Healthy subject were administered nitroglycerin as well and scanned at a pain free baseline and after 3 hours in order to compare the response. The rebound headache that followed acute drug withdrawal were used as a surrogate paradigm of spontaneous attack. Patients with chronic migraine and medication overuse were hospitalized for a supervised withdrawal program at the Mondino Foundation; during the program if they experienced a rebound headache attack, they were scanned with a rs-fMRI acquisition. The acquired imagines were analyzed with the same procedure regarding the evaluation of static and dynamic functional connectivity fluctuation.

Interventions

None listed

Sponsors

IRCCS National Neurological Institute C. Mondino Foundation
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Episodic migraineurs Inclusion Criteria: * age between 18-60 years; * diagnosis of episodic migraine without aura developed before the age of 50; * no current prophylactic treatment for migraine prevention; * chronic migraineurs with medication overuse according to the ICHDIII criteria

Exclusion criteria

* chronic or medication-overuse headache or cluster headache diagnosis; * any chronic pain condition or disorders other than migraine; * an alleged diagnosis of major psychiatric disorders such as depression, bipolar affective disorder and schizophrenia; * a diagnosis of tension type headache with a frequency of more than 5 days per month; * any cardiovascular diseases in which the NTG use could be contraindicated; * blood pressure hypotension, closed angle glaucoma, anaemia; * women in child bearing, breast feeding; continuous use of benzodiazepines; * any neuroradiological pathological findings at a previous MRI scan of the head. Chronic migraineurs Inclusion Criteria: * age between 18-60 years; * diagnosis of migraine without aura developed before the age of 50 according to the ICHD III criteria; * currently chronic migraineurs with medication overuse according to The International Classification of Headache Disorders 3rd edition (ICHDIII) criteria.

Design outcomes

Primary

MeasureTime frameDescription
Functional Connectivity (FC) changesUp to 6 hoursFunctional connectivity pattern of changes profiling the different condition of the migraine experience. To depict the static and dynamics changes of brain activity during a migraine attack; ii) To validate the use of the NTG-induced attacks paradigm as a reliable instrument combined with an fMRI approach to compare the induced vs the spontaneous attack; iii) To describe possible differences in brain activity between attacks in chronic and episodic migraineurs.

Secondary

MeasureTime frameDescription
Throbbing pain (number)Up to 6 hoursAs a feature of the migraine attack. To acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Abortive medication (number of intake/month)Up to 6 hoursTo acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Magnetic Resonance Imaging (MRI)Up to 6 hoursTo acquire sufficient MRI to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms. This can be achieved by combining clinical, psychological, biological, neurophysiological and MRI-derived features into a multimodal multi-parametric approach suitable for patient's classification. The ML and DL approaches could also be adopted to predict chronification, as well as the response to a withdrawal program for medication overuse headache.
Monthly migraine frequency (day/month)Up to 6 hoursTo acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Aggravation by movement (number)Up to 6 hoursAs a feature of the migraine attack. To acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Nausea (number)Up to 6 hoursAs a feature of the migraine attack.To acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Vomiting (number)Up to 6 hoursAs a feature of the migraine attack.To acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Photophobia (number)Up to 6 hoursAs a feature of the migraine attack.To acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Phonophobia (number)Up to 6 hoursTo acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.
Disease duration (years)Up to 6 hoursTo acquire clinical data to identify feature patterns that can profile patient's condition using machine learning (ML) and deep learning (DL) algorithms.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026